Background illustration for clinical trials search

Ovarian Cancer Clinical Trials

Browse 1,660 ovarian cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

for
Invasive Ductal Breast Carcinoma,
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05837767

Recruiting

PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor-To-Normal Liver Ratio And Tumor Dose Using The Trinav Infusion System

for
Tumor, Liver
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07444645

Recruiting

Project: Every Child for Younger Patients With Cancer

for
Adrenal Gland Pheochromocytoma, Carcinoma In Situ,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 25

Code: NCT02402244

Recruiting

Cannabis Oil for Pain Effectiveness

for
Cancer, Chronic Pain
Location: Hamilton
Sponsor: Aurora Cannabis Inc

Sex: All

Age: 25 - 70

Code: NCT03522467

Phase 2, Recruiting

Study of Endocrine-Related Conditions and Physiology

for
Endocrine Disease
Location: Bethesda MD
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sex: All

Age: 18 - 70+

Code: NCT03867448

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Preserving Physical Function in Older Adults With Cancer: Impact of an Optimizing Nutrition Intervention Applied Before and After Surgery

for
Cancer
Location: Durham NC
Sponsor: VA Office of Research and Development

Sex: All

Age: 55+

Code: NCT05912257

Recruiting

myCare-102: Clinical Utility and Usability of Cellworks Singula™ and Cellworks Ventura™ Reports

for
Cancer, Relapsed Cancer, Refractory Cancer
Location: Sioux Falls SD
Sponsor: Cellworks Group Inc.

Sex: All

Age: 0+

Code: NCT05693831

Recruiting

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

for
Solid Tumors, Hematologic Malignancies
Location: Quebec, Sherbrooke, White Plains NY, New York NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT03486873

Phase 3, Recruiting

A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid Tumors

for
Refractory Solid Tumors
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 1 - 25

Code: NCT06006273

Phase 1, Recruiting

Inhaled Cannabinoids Versus Immediate-release Oral Opioids for the Management of Breakthrough Cancer Pain

for
Cancer, Breakthrough Cancer Pain
Location: Berlin NJ
Sponsor: Tetra Bio-Pharma

Sex: All

Age: 18+

Code: NCT03564548

Phase 2, Recruiting

AMT-116 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Dallas TX
Sponsor: Multitude Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT05725291

Phase 1, Recruiting

B7-H3.CD28Z.CART in Solid Tumors

for
Pediatric Solid Tumor, Neuroblastoma
Location: Boston MA
Sponsor: Robbie Majzner

Sex: All

Age: 0 - 30

Code: NCT07358260

Phase 1, Recruiting

A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial

for
Malignant Solid Neoplasm
Location: Vancouver WA, Longview WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT06771739

Recruiting

Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.

for
Small Cell Lung Cancer, Advanced Solid Malignant Tumor
Location: Boston MA, Fairfax VA, Canton OH, Detroit MI,
Sponsor: Chipscreen Biosciences, Ltd.

Sex: All

Age: 18+

Code: NCT05271292

Phase 1, Phase 2, Recruiting

ORIC-114 in Combination With Subcutaneous Amivantamab in Patients With EGFR Exon20 Insertion Mutant NSCLC

for
Solid Tumors, EGFR Exon 20 Insertion Mutations, NSCLC,
Location: New York NY, Fairfax VA
Sponsor: ORIC Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06816992

Phase 1, Recruiting

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

for
Advanced Solid Malignancies
Location: Boston MA, New York NY, Chicago IL, Houston TX,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT05417594

Phase 1, Phase 2, Recruiting

Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)

for
Advanced Cancer, Anal Carcinoma, Anal Cancer, Biliary Cancer,
Location: New Brunswick NJ
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT02628067

Phase 2, Recruiting

Collection and Storage of Tissue and Blood Samples From Patients With Cancer

for
Hematopoietic and Lymphatic System Neoplasm,
Location: New York NY, Augusta GA, Grand Rapids MI, Chicago IL,
Sponsor: National Cancer Institute LAO

Sex: All

Age: 0+

Code: NCT02474160

Recruiting

Pembrolizumab, Ibrutinib and Rituximab in PCNSL

for
Primary Central Nervous System Lymphoma, Recurrent Cancer,
Location: Boston MA, New York NY
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT04421560

Phase 1, Phase 2, Recruiting

A ProspectiveTrial Using Video Images in Advance Care Planning in Hospitalized Seriously Ill Patients With Advanced Cancer

for
Advanced Cancer
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 21+

Code: NCT01527331

Recruiting

What is ovarian cancer?

Ovarian cancer begins in or near the ovaries. About 9 in 10 cases are epithelial, and most of those are high grade serous tumors that research now shows usually start in the fallopian tubes rather than the ovary. Rarer types begin in the egg cells or in hormone producing cells. It is hard to catch early. The ovaries sit deep in the pelvis, and early symptoms like bloating, pelvic or back pain, feeling full quickly, and urinary urgency are vague and common. The most frequent sign at diagnosis is abdominal swelling from fluid, which means the cancer is already advanced.

Treatment has changed. Surgery to remove as much tumor as possible, followed by platinum chemotherapy, is still the foundation. Since 2014 PARP inhibitor pills have been used to delay recurrence in BRCA mutated and similar tumors, and testing every patient for these mutations is now standard. In 2022 the first antibody drug conjugate for ovarian cancer was approved for platinum resistant disease, with full approval in 2024. Prevention has moved too. Because most cancers start in the tubes, removing only the fallopian tubes during other pelvic surgery is being tested as a way to prevent cancer without early menopause.

Ovarian cancer shares its inherited risk genes with breast, pancreatic, and prostate cancer. Our cancer treatment guide explains how targeted therapies work.

Types of ovarian cancer clinical trials

How is ovarian cancer diagnosed and tested?

Who can participate in ovarian cancer clinical trials?

The stages of ovarian cancer, and why they matter for trials

How to enroll in an ovarian cancer clinical trial